Cargando…
Toxic Myelitis and Arachnoiditis After Intrathecal Delivery of Bupivacaine via an Implanted Drug Delivery System: Case Report and Review of the Literature
The off-label usage of amino-amide anesthetics in intrathecal drug delivery systems (IDDS) for the treatment of chronic non-malignant and malignant pain is supported in the polyanalgesic consensus guidelines as a second-line adjunctive therapy. Although strong evidence for its clinical efficacy is l...
Autores principales: | Huang, Meng, Dalm, Brian, Simpson, Richard K |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5922505/ https://www.ncbi.nlm.nih.gov/pubmed/29719742 http://dx.doi.org/10.7759/cureus.2240 |
Ejemplares similares
-
Pre- and Post-Interventional Changes in Physiological Profiles in a Patient Presenting With Opioid Withdrawal After Intrathecal Drug Delivery System Failure Related to Assumed Catheter Microfracture
por: Ehsanian, Reza, et al.
Publicado: (2021) -
Intrathecal Drug Delivery: Advances and Applications in the Management of Chronic Pain Patient
por: De Andres, Jose, et al.
Publicado: (2022) -
Corrigendum: Intrathecal drug delivery: Advances and applications in the management of chronic pain patient
por: De Andres, Jose, et al.
Publicado: (2023) -
Intrathecal Administration of Ziconotide as a Potential Treatment for Chronic Migraines
por: Holden, Ryan, et al.
Publicado: (2022) -
Intrathecal Medication From Pain Pump Caused Prolonged Alteration in Mental Status Following Decompression of Severe Spinal Stenosis
por: Saadeh, Yamaan S, et al.
Publicado: (2022)